125 related articles for article (PubMed ID: 25395358)
1. Evaluation of hypericin: effect of aggregation on targeting biodistribution.
Liu X; Jiang C; Li Y; Liu W; Yao N; Gao M; Ji Y; Huang D; Yin Z; Sun Z; Ni Y; Zhang J
J Pharm Sci; 2015 Jan; 104(1):215-22. PubMed ID: 25395358
[TBL] [Abstract][Full Text] [Related]
2. Radioiodinated hypericin: its biodistribution, necrosis avidity and therapeutic efficacy are influenced by formulation.
Cona MM; Alpizar YA; Li J; Bauwens M; Feng Y; Sun Z; Zhang J; Chen F; Talavera K; de Witte P; Verbruggen A; Oyen R; Ni Y
Pharm Res; 2014 Feb; 31(2):278-90. PubMed ID: 23934256
[TBL] [Abstract][Full Text] [Related]
3. Radiopharmaceutical evaluation of (131)I-protohypericin as a necrosis avid compound.
Liu X; Feng Y; Jiang C; Lou B; Li Y; Liu W; Yao N; Gao M; Ji Y; Wang Q; Huang D; Yin Z; Sun Z; Ni Y; Zhang J
J Drug Target; 2015 Jun; 23(5):417-26. PubMed ID: 25655506
[TBL] [Abstract][Full Text] [Related]
4. Sodium cholate, a solubilizing agent for the necrosis avid radioiodinated hypericin in rabbits with acute myocardial infarction.
Cona MM; Feng Y; Zhang J; Li Y; Verbruggen A; Oyen R; Ni Y
Drug Deliv; 2015 May; 22(3):427-35. PubMed ID: 24417698
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Preclinical Evaluation of Radioiodinated Hypericin Dicarboxylic Acid as a Necrosis Avid Agent in Rat Models of Induced Hepatic, Muscular, and Myocardial Necroses.
Li J; Zhang J; Yang S; Jiang C; Zhang D; Jin Q; Wang Q; Wang C; Ni Y; Yin Z; Song S
Mol Pharm; 2016 Jan; 13(1):232-40. PubMed ID: 26568406
[TBL] [Abstract][Full Text] [Related]
6. Targetability and biodistribution of radioiodinated hypericin: comparison between microdosing and carrier-added preparations.
Cona MM; Li J; Feng Y; Chen F; Verbruggen A; Witte Pd; Oyen R; Ni Y
Anticancer Agents Med Chem; 2014; 14(6):852-61. PubMed ID: 24102315
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution and anti-tumor efficacy of intratumorally injected necrosis-avid theranostic agent radioiodinated hypericin in rodent tumor models.
Liu W; Zhang D; Feng Y; Li Y; Huang D; Jiang C; Gao M; Peng F; Wang X; Jing S; Jiang X; Ni Y; Zhang J
J Drug Target; 2015 May; 23(4):371-9. PubMed ID: 25572455
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and radiation dosimetry of radioiodinated hypericin as a cancer therapeutic.
Cona MM; Koole M; Feng Y; Liu Y; Verbruggen A; Oyen R; Ni Y
Int J Oncol; 2014 Mar; 44(3):819-29. PubMed ID: 24366374
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Necrosis Avidity and Potential for Rapid Imaging of Necrotic Myocardium of Radioiodinated Hypocrellins.
Jin Q; Zhao J; Gao M; Feng Y; Liu W; Yin Z; Li T; Song S; Ni Y; Zhang J; Huang D; Zhang D
Mol Imaging Biol; 2018 Aug; 20(4):551-561. PubMed ID: 29305726
[TBL] [Abstract][Full Text] [Related]
10. First preclinical evaluation of mono-[123I]iodohypericin as a necrosis-avid tracer agent.
Ni Y; Huyghe D; Verbeke K; de Witte PA; Nuyts J; Mortelmans L; Chen F; Marchal G; Verbruggen AM; Bormans GM
Eur J Nucl Med Mol Imaging; 2006 May; 33(5):595-601. PubMed ID: 16450141
[TBL] [Abstract][Full Text] [Related]
11. Improvement of solubility and targetability of radioiodinated hypericin by using sodium cholate based solvent in rat models of necrosis.
Ji Y; Zhan Y; Jiang C; Jiang X; Gao M; Liu W; Li Y; Wang J; Wang Q; Cona MM; Yao N; Wang X; Fang Z; Yin Z; Zhang J; Sun Z; Ni Y
J Drug Target; 2014 May; 22(4):304-12. PubMed ID: 24328682
[TBL] [Abstract][Full Text] [Related]
12. Improved clearance of radioiodinated hypericin as a targeted anticancer agent by using a duodenal drainage catheter in rats.
Cona MM; Feng Y; Verbruggen A; Oyen R; Ni Y
Exp Biol Med (Maywood); 2013 Dec; 238(12):1437-49. PubMed ID: 24146264
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of iodine-123-labeled hypericin and (99m)Tc-labeled hexakis [2-methoxy isobutyl isonitrile] in a rabbit model of myocardial infarction.
Cona MM; Feng Y; Li Y; Chen F; Vunckx K; Zhou L; Van Slambrouck K; Rezaei A; Gheysens O; Nuyts J; Verbruggen A; Oyen R; Ni Y
J Cardiovasc Pharmacol; 2013 Sep; 62(3):304-11. PubMed ID: 23714775
[TBL] [Abstract][Full Text] [Related]
14. Improved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapy.
Gao L; Zhang J; Ma T; Yao N; Gao M; Shan X; Ni Y; Shao H; Xu K
Oncotarget; 2016 Aug; 7(32):51450-51461. PubMed ID: 27285983
[TBL] [Abstract][Full Text] [Related]
15. The impact of aggregation on the biodistribution of hypericin.
Van De Putte M; Roskams T; Bormans G; Verbruggen A; De Witte PA
Int J Oncol; 2006 Mar; 28(3):655-60. PubMed ID: 16465370
[TBL] [Abstract][Full Text] [Related]
16. Exploring diagnostic potentials of radioiodinated sennidin A in rat model of reperfused myocardial infarction.
Jiang C; Gao M; Li Y; Huang D; Yao N; Ji Y; Liu X; Zhang D; Wang X; Yin Z; Jing S; Ni Y; Zhang J
Int J Pharm; 2015 Nov; 495(1):31-40. PubMed ID: 26302863
[TBL] [Abstract][Full Text] [Related]
17. Effects of skeleton structure on necrosis targeting and clearance properties of radioiodinated dianthrones.
Zhang D; Jiang C; Yang S; Gao M; Huang D; Wang X; Shao H; Feng Y; Sun Z; Ni Y; Zhang J; Yin Z
J Drug Target; 2016; 24(6):566-77. PubMed ID: 26586010
[TBL] [Abstract][Full Text] [Related]
18. Pretargeting of necrotic tumors with biotinylated hypericin using 123I-labeled avidin: evaluation of a two-step strategy.
Marysael T; Bauwens M; Ni Y; Bormans G; Rozenski J; de Witte P
Invest New Drugs; 2012 Dec; 30(6):2132-40. PubMed ID: 22187204
[TBL] [Abstract][Full Text] [Related]
19. Preparation and validation of cyclodextrin-based excipients for radioiodinated hypericin applied in a targeted cancer radiotherapy.
Li Y; Wang S; Jiang X; Wang X; Zhou X; Wan L; Zhao H; Zhou Z; Gao L; Huang G; Ni Y; He X
Int J Pharm; 2021 Apr; 599():120393. PubMed ID: 33639227
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and preliminary evaluation of mono-[123I]iodohypericin monocarboxylic acid as a necrosis avid imaging agent.
Fonge H; Jin L; Wang H; Ni Y; Bormans G; Verbruggen A
Bioorg Med Chem Lett; 2007 Jul; 17(14):4001-5. PubMed ID: 17507220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]